A Role for GDNF and Soluble APP as Biomarkers of Amyotrophic Lateral Sclerosis Pathophysiology

The current inability of clinical criteria to accurately identify the “at-risk group” for Amyotrophic Lateral Sclerosis (ALS) development as well as its unknown etiology are fueling the interest in biomarkers aimed at completing clinical approaches for the diagnosis. The Glial cell line-derived neur...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanga, Serena, Brambilla, Liliana, Tasiaux, Bernadette, Dang, Anh H., Ivanoiu, Adrian, Octave, Jean-Noël, Rossi, Daniela, van Pesch, Vincent, Kienlen-Campard, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988896/
https://www.ncbi.nlm.nih.gov/pubmed/29899726
http://dx.doi.org/10.3389/fneur.2018.00384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988896/
https://www.ncbi.nlm.nih.gov/pubmed/29899726
http://dx.doi.org/10.3389/fneur.2018.00384

Ejemplares similares